Digitization won’t erase printing. Sell the process.
The less paper you ship, the more pharma labeling and trial packs shift from “printed matter” to “process assurance.” How much responsibility should a printer take on?
Pharmaceutical package inserts have entered an era where paper is no longer bundled in the box. Yet the outside of the carton now carries heavier responsibility than before. Digitization hasn’t just reduced print—it has increased the number of systems where printing is not allowed to fail.
Gathered with AI. Thought through on the shop floor. Written for the future of print.
BPJ WIRE: stories selected and drafted by the BPJ desk from world news, fact-checked against the source ledger — published alongside the editor's own picks.
Translated from Japanese by AI. The Japanese original is authoritative.
A tiny barcode on an outer box fails to scan, and you can’t reach the drug information.
In Japan, starting August 1, 2021, the default requirement to include paper package inserts for prescription drugs was abolished. The system is shifting to one where inserts are primarily accessed as electronic package inserts hosted by PMDA (the Pharmaceuticals and Medical Devices Agency—Japan’s regulator).…
The rest is for members
Read the full article. Our feature reports also carry an archive-grade one-page brief (BPJ VISUAL BRIEF) — every figure with its source.
Already a member? Log in
Beyond Printing Journal — read the world through print, and print the future.